penicillamine chelation
Selected indexed studies
- Wilson's disease: overview. (Med Clin (Barc), 2023) [PMID:36697289]
- Copper Chelation by Penicillamine Protects Against Doxorubicin-Induced Cardiomyopathy by Suppressing FDX1-Mediated Cuproptosis. (Biomolecules, 2025) [PMID:41008627]
- Wilson Disease: Diagnosis, Treatment, and Follow-up. (Clin Liver Dis, 2017) [PMID:28987261]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Wilson's disease: overview. (2023) pubmed
- Copper Chelation by Penicillamine Protects Against Doxorubicin-Induced Cardiomyopathy by Suppressing FDX1-Mediated Cuproptosis. (2025) pubmed
- Wilson Disease: Diagnosis, Treatment, and Follow-up. (2017) pubmed
- Copper chelation by d-penicillamine alleviates melanocyte death induced by rhododendrol without inhibiting tyrosinase. (2023) pubmed
- Chelation therapy in Wilson's disease: from D-penicillamine to the design of selective bioinspired intracellular Cu(I) chelators. (2012) pubmed
- Wilson's disease. (2000) pubmed
- Canine Copper-Associated Hepatitis. (2017) pubmed
- D-penicillamine-induced autoimmune disorders. (2019) pubmed
- Wilson's disease. (2007) pubmed
- D-penicillamine-associated neutropenia in a Doberman pinscher. (2023) pubmed